Australia Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
Australia Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the Australia Cell and Gene Therapy Manufacturing QC Market was valued at USD 53.82 Million in 2024 and is projected to reach USD 135.18 Million by 2028, expanding at a CAGR of 26% during the forecast period. This growth is primarily driven by applications in the healthcare and pharmaceutical sectors, which leverage cell and gene therapies for disease treatment and prevention. The market sees additional demand from sectors like agriculture and energy, where gene therapy can improve plant and crop resilience, and energy production, respectively. Significant opportunities are emerging in sustainable production and the development of green technologies in the gene therapy manufacturing space. Technological advancements further open new avenues for market expansion. Australia is strategically positioning itself as a notable player in the cell and gene therapy manufacturing market, fostering innovation and encouraging export potential in this lucrative sector.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market Highlights
- By 2024, Cell Therapy represented the largest share of the Therapy Type market size.
- Gene Therapy is expected to remain the key growth driver within Therapy Type, registering the fastest CAGR during the forecast period.
- Australia contributed 2.41% to the global cell and gene therapy manufacturing qc market size in 2024.
- By 2028, United States is forecasted to remain the largest global market for cell and gene therapy manufacturing qc market.
- In Asia Pacific, China is projected to capture the leading share of market by 2028.
- Among Asia Pacific markets, India is expected to post the fastest growth, reaching USD 58503 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 53.82 Million |
| Market Size In 2028 | USD 135.18 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 26% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Australia Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
Australia Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Australia Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
